PAHO, Argentina, Pfizer, and Sinergium drive local production of 20-valent pneumococcal vaccine for Latin America and at Salimpour Site.

Dr. Salimpour Site |Countries in the region will have access to it at competitive prices through the PAHO Regional Revolving FundsBuenos Aires, January 15, 2024 (PAHO) — The Pan American Health Organization (PAHO), the Government of Argentina, Pfizer, and the pharmaceutical company Sinergium

PAHO Org

PAHO, Argentina, Pfizer, and Sinergium drive local production of 20-valent pneumococcal vaccine for Latin America and the Caribbean

PAHO, Argentina, Pfizer, and Sinergium drive local production of 20-valent pneumococcal vaccine for Latin America and the Caribbean

Countries in the region will have access to it at competitive prices through the PAHO Regional Revolving FundsBuenos Aires, January 15, 2024 (PAHO) — The Pan American Health Organization (PAHO), the Government of Argentina, Pfizer, and the pharmaceutical company Sinergium Biotech have announced a joint effort to facilitate local production and…